Lorenzo Bazan MD , Francesco Gentile MD , Paolo Sciarrone MD , Francesco Buoncristiani MD , Giorgia Panichella MD , Simone Gasparini MD , Claudia Taddei MSc , Elisa Poggianti MSc , Iacopo Fabiani MD, PhD , Christina Petersen MD , Giuseppe Emanuele Lio PhD , Patrizio Lancellotti MD, PhD , Claudio Passino MD , Michele Emdin MD, PhD , Vladislav Chubuchny MD , Alberto Giannoni MD, PhD
{"title":"Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients With Reduced and Mildly Reduced Ejection Fraction","authors":"Lorenzo Bazan MD , Francesco Gentile MD , Paolo Sciarrone MD , Francesco Buoncristiani MD , Giorgia Panichella MD , Simone Gasparini MD , Claudia Taddei MSc , Elisa Poggianti MSc , Iacopo Fabiani MD, PhD , Christina Petersen MD , Giuseppe Emanuele Lio PhD , Patrizio Lancellotti MD, PhD , Claudio Passino MD , Michele Emdin MD, PhD , Vladislav Chubuchny MD , Alberto Giannoni MD, PhD","doi":"10.1016/j.echo.2025.04.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>An echocardiographic algorithm to estimate pulmonary capillary wedge pressure (ePCWP) and pulmonary vascular resistance (ePVR) has been recently validated versus right heart catheterization.</div></div><div><h3>Objective</h3><div>To assess the prognostic significance of these measures in heart failure (HF) patients with reduced and mildly reduced ejection fraction.</div></div><div><h3>Methods</h3><div>Consecutive outpatients with HF and left ventricular ejection fraction (LVEF) <50% undergoing echocardiography were selected and followed up for the composite end point of all-cause death or HF hospitalization.</div></div><div><h3>Results</h3><div>Out of 2,214 patients (71 ± 12 years, 76% males, LVEF 35% ± 9%), ePCWP (16 ± 6 mm Hg) was elevated (>15 mm Hg) in 52% of cases and ePVR (1.7 ± 0.7 Wood units) was elevated (>2 Wood units) in 25% of cases. Patients with increased ePCWP were older and had a higher New York Heart Association class, more pronounced cardiac remodeling, systolic/diastolic dysfunction, and neurohormonal activation, particularly when ePVR was also elevated (<em>P</em> < .001). Over a median follow-up of 33 (17-48) months, both measures stratified patients for the risk of the primary end point (log-rank 151 for ePCWP and 60 for ePVR; <em>P</em> < .001). At adjusted regression analysis, ePCWP (hazard ratio for 1 mm Hg increase 1.03 [95% CI, 1.01-1.04]; <em>P</em> < .001) but not ePVR (<em>P</em> = .07) predicted the primary end point, even in patients with atrial fibrillation (<em>P</em> = .019), outperforming current diastolic dysfunction grading (<em>P</em> < .001) and both E/e’ and left atrial volume index (<em>P</em> < .001). The addition of ePCWP to a multivariable prognostic model improved the accuracy of risk prediction (<em>P</em> < .001).</div></div><div><h3>Conclusion</h3><div>The echocardiographic estimates of PCWP retained clinical and prognostic significance in a large contemporary cohort of patients with chronic HF and LVEF <50%.</div></div>","PeriodicalId":50011,"journal":{"name":"Journal of the American Society of Echocardiography","volume":"38 7","pages":"Pages 586-598"},"PeriodicalIF":5.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Society of Echocardiography","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0894731725002123","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
An echocardiographic algorithm to estimate pulmonary capillary wedge pressure (ePCWP) and pulmonary vascular resistance (ePVR) has been recently validated versus right heart catheterization.
Objective
To assess the prognostic significance of these measures in heart failure (HF) patients with reduced and mildly reduced ejection fraction.
Methods
Consecutive outpatients with HF and left ventricular ejection fraction (LVEF) <50% undergoing echocardiography were selected and followed up for the composite end point of all-cause death or HF hospitalization.
Results
Out of 2,214 patients (71 ± 12 years, 76% males, LVEF 35% ± 9%), ePCWP (16 ± 6 mm Hg) was elevated (>15 mm Hg) in 52% of cases and ePVR (1.7 ± 0.7 Wood units) was elevated (>2 Wood units) in 25% of cases. Patients with increased ePCWP were older and had a higher New York Heart Association class, more pronounced cardiac remodeling, systolic/diastolic dysfunction, and neurohormonal activation, particularly when ePVR was also elevated (P < .001). Over a median follow-up of 33 (17-48) months, both measures stratified patients for the risk of the primary end point (log-rank 151 for ePCWP and 60 for ePVR; P < .001). At adjusted regression analysis, ePCWP (hazard ratio for 1 mm Hg increase 1.03 [95% CI, 1.01-1.04]; P < .001) but not ePVR (P = .07) predicted the primary end point, even in patients with atrial fibrillation (P = .019), outperforming current diastolic dysfunction grading (P < .001) and both E/e’ and left atrial volume index (P < .001). The addition of ePCWP to a multivariable prognostic model improved the accuracy of risk prediction (P < .001).
Conclusion
The echocardiographic estimates of PCWP retained clinical and prognostic significance in a large contemporary cohort of patients with chronic HF and LVEF <50%.
期刊介绍:
The Journal of the American Society of Echocardiography(JASE) brings physicians and sonographers peer-reviewed original investigations and state-of-the-art review articles that cover conventional clinical applications of cardiovascular ultrasound, as well as newer techniques with emerging clinical applications. These include three-dimensional echocardiography, strain and strain rate methods for evaluating cardiac mechanics and interventional applications.